Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	27708
Country	China

Received	2016-06-13 08:55
Peer-Review Started	2016-06-17 17:10
To Make the First Decision	2016-07-27 08:18
Return for Revision	2016-07-30 18:29
Revised	2016-08-01 22:24
Second Decision	2016-08-25 08:14
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2016-08-31 12:14
Articles in Press	2016-08-31 12:14
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-11-07 20:30
Publish the Manuscript Online	2016-11-14 09:26

ISSN	1948-5204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests
Manuscript Source	Invited Manuscript
All Author List	Le-Le Song and Yue-Min Li
Funding Agency and Grant Number
Corresponding Author	Le-Le Song, MD, PhD, Department of Radiotherapy, the Chinese PLA 309 Hospital, No. 17, Heishanhu Road, Haidian District, Beijing 100091, China. songlele@sina.com
Key Words	Colorectal cancer; Adenoma; Fecal immu­nochemical test; Fecal DNA; SEPT9; Septin 9
Core Tip	The choice of colorectal cancer (CRC) screen-ing methods is crucial for screening validity and com-pliance. Currently, the fecal immunochemical test (FIT), fecal DNA and the blood-based SEPT9 assays are the three in vitro diagnostic tests for CRC screening. In this article, we reviewed the current application of the three types of assays and compared their performance in CRC screening. FIT is still the cheapest method with high screening validity, and fecal DNA tests also exhibit high validity but its price is high. In contrast, the SEPT9 assay showed high compliance with acceptable performance. The choice of screening test may depend on the balance of performance, compliance and costs.
Publish Date	2016-11-14 09:26
Citation	Song LL, Li YM. Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests. World J Gastrointest Oncol 2016; 8(11): 793-800
URL	http://www.wjgnet.com/1948-5204/full/v8/i11/793.htm
DOI	http://dx.doi.org/10.4251/wjgo.v8.i11.793

Full Article (PDF)	WJGO-8-793.pdf
Full Article (Word)	WJGO-8-793.doc
Manuscript File	27708-Review.docx
Answering Reviewers	27708-Answering reviewers.pdf
Audio Core Tip	27708-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	27708-Conflict-of-interest statement.pdf
Copyright License Agreement	27708-Copyright assignment.pdf
Peer-review Report	27708-Peer-review(s).pdf
Scientific Misconduct Check	27708-Scientific misconduct check.pdf
Scientific Editor Work List	27708-Scientific editor work list.pdf